Marina Stukova

Influenza Virus NS Vectors Expressing the<i>Mycobacterium tuberculosis</i>ESAT-6 Protein Induce CD4⁺Th1 Immune Response and Protect Animals against Tuberculosis Challenge

Sabine Sereinig, Marina Stukova, Natalia Zabolotnyh et al. · Clinical and Vaccine Immunology · 2006 · 64 citations · Full text

SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19

Oksana V. Stanevich, Evgeniia Alekseeva, Maria V. Sergeeva et al. · Nature Communications · 2023 · 59 citations · Full text

Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo–Controlled, Randomized Double–Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine

Larisa Rudenko, Irina Kiseleva, Anatoly Naykhin et al. · PLoS ONE · 2014 · 57 citations · Full text

Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan

Kunsulu Zakaryа, Lespek Kutumbetov, Mukhit Orynbayev et al. · EClinicalMedicine · 2021 · 54 citations · Full text

Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein

Marina Stukova, Sabine Sereinig, N.V. Zabolotnyh et al. · Tuberculosis · 2006 · 51 citations

Vaccination, Vaccine Development, Vaccine Target +9